11 Einträge gefunden

1. High expression of CD40 on B-cell precursor acute lymphoblastic leukemia blasts is an independent risk factor associated with improved survival and enhanced capacity to up-regulate the death receptor CD95.

   1. Troeger, Anja
   2. Glouchkova, Ludmila
   3. Ackermann, Birgit
   4. Escherich, Gabriele
   5. Meisel, Roland
   6. Hanenberg, Helmut
   7. Boer, den

   2008 - Forschungsinformationssystem des UKE
2. The expression of 70 apoptosis genes in relation to lineage, genetic subtype, cellular drug resistance, and outcome in childhood acute lymphoblastic leukemia.

   1. Holleman, Amy
   2. Boer, den
   3. Monique, L
   4. Menezes, de
   5. Renée, X
   6. Cheok, Meyling H
   7. Janka-Schaub, Gritta

   2006 - Forschungsinformationssystem des UKE
3. Expression of the outcome predictor in acute leukemia 1 (OPAL1) gene is not an independent prognostic factor in patients treated according to COALL or St Jude protocols.

   1. Holleman, Amy
   2. Boer, den
   3. Monique, L
   4. Cheok, Meyling H
   5. Kazemier, Karin M
   6. Pei, Deqing
   7. Janka-Schaub, Gritta

   2006 - Forschungsinformationssystem des UKE
4. Identification of genes associated with chemotherapy crossresistance and treatment response in childhood acute lymphoblastic leukemia.

   1. Lugthart, Sanne
   2. Cheok, Meyling H
   3. Boer, den
   4. Monique, L
   5. Yang, Wenjian
   6. Holleman, Amy
   7. Cheng, Cheng

   2005 - Forschungsinformationssystem des UKE
5. Asparagine synthetase expression is linked with L-asparaginase resistance in TEL-AML1-negative but not TEL-AML1-positive pediatric acute lymphoblastic leukemia.

   1. Stams, Wendy A G
   2. Boer, den
   3. Monique, L
   4. Holleman, Amy
   5. Appel, Inge M
   6. Beverloo, H Berna
   7. Janka-Schaub, Gritta

   2005 - Forschungsinformationssystem des UKE
6. Effect of the histone deacetylase inhibitor depsipeptide on B-cell differentiation in both TEL-AML1-positive and negative childhood acute lymphoblastic leukemia.

   1. Stams, [Unbekannt]
   2. Wendy, A G
   3. Den, Boer
   4. Monique, L
   5. Beverloo, [Unbekannt]
   6. Berna, H
   7. Kazemier, [Unbekannt]

   2005 - Forschungsinformationssystem des UKE - frei zugänglich
7. Decreased PARP and procaspase-2 protein levels are associated with cellular drug resistance in childhood acute lymphoblastic leukemia.

   1. Holleman, Amy
   2. Boer, den
   3. Monique, L
   4. Kazemier, Karin M
   5. Beverloo, H Berna
   6. Janka-Schaub, Gritta
   7. Anne, R M

   2005 - Forschungsinformationssystem des UKE
8. Expression levels of TEL, AML1, and the fusion products TEL-AML1 and AML1-TEL versus drug sensitivity and clinical outcome in t(12;21)-positive pediatric acute lymphoblastic leukemia.

   1. Stams, [Unbekannt]
   2. Wendy, A G
   3. Den, Boer
   4. Monique, L
   5. Beverloo, [Unbekannt]
   6. Berna, H
   7. Meijerink, [Unbekannt]

   2005 - Forschungsinformationssystem des UKE
9. Gene-expression patterns in drug-resistant acute lymphoblastic leukemia cells and response to treatment.

   1. Holleman, Amy
   2. Cheok, Meyling H
   3. Boer, den
   4. Monique, L
   5. Yang, Wenjian
   6. Veerman, Anjo J P
   7. Kazemier, Karin M

   2004 - Forschungsinformationssystem des UKE
10. Differential mRNA expression of Ara-C-metabolizing enzymes explains Ara-C sensitivity in MLL gene-rearranged infant acute lymphoblastic leukemia.

    1. Stam, Ronald W
    2. Boer, den
    3. Monique, L
    4. Meijerink, Jules P P
    5. Ebus, Marli E G
    6. Peters, Godefridus J
    7. Janka-Schaub, Gritta

    2003 - Forschungsinformationssystem des UKE
11. Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia.

    1. Holleman, Amy
    2. Boer, den
    3. Monique, L
    4. Janka-Schaub, Gritta
    5. Janka-Schaub, Gritta E
    6. Pieters, Rob

    2003 - Forschungsinformationssystem des UKE